Articles

CDD gains grants

CDD awarded two SBIR grants on digital representation of chemical mixtures, deep learning strategy for drug discovery
Written byMel J. Yeates
| 3 min read

BURLINGAME, Calif.—In late 2018, Collaborative Drug Discovery Inc. (CDD) announced that they had won a competitive, peer-reviewed Phase 1 SBIR grant from the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS), entitled “Digital representation of chemical mixtures to aid drug discovery and formulation.” CDD proposes to develop a suite of software modules to enable scientists to unambiguously represent chemical mixtures in standard machine-readable formats.

The International Chemical Identifier (InChI) has emerged over the past decade as the predominant international standard to concisely represent chemical structures as encoded text strings that computers can quickly index, sort, search and compare. However, in practice, chemicals are typically formulated as mixtures. Even if a mixture consists of one principal ingredient that is well represented by an InChI identifier, the mixture may also contain solvents, adjuncts, cofactors, impurities, etc. that also need to be properly recorded.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.